Gestational Diabetes Mellitus in Sardinia
Results from an early, universal screening procedure
- Cinzia Murgia, MD1,
- Rachele Berria, MD2,
- Luigi Minerba, MD3,
- Barbara Malloci, MD1,
- Claudia Daniele, MD1,
- Pierina Zedda, RN1,
- M. Giovanna Ciccotto, MD1,
- Simonetta Sulis, MD1,
- Michela Murenu, MD1,
- Franco Tiddia, MD4,
- Mario Manai, MD5 and
- Gian Benedetto Melis, MD1
- 1Clinica Ostetrica e Ginecologica, Università degli Studi di Cagliari, Ospedale San Giovanni di Dio, Cagliari, Italy
- 2Department of Obstetrics and Gynecology, Case Western Reserve University, Cleveland, Ohio
- 3Dipartimento di Sanità Pubblica, Università degli Studi di Cagliari, Italy
- 4Laboratorio Analisi Chimico Clinche e Microbiologia, Ospedale San Giovanni di Dio, Cagliari, Italy
- 5Servizio di Diabetologia, Ospedale San Giovanni di Dio, Cagliari, Italy
- Address correspondence to Cinzia Murgia, MD, Clinica Ostetrica e Ginecologica, Università degli Studi di Cagliari, Ospedale San Giovanni di Dio, Via Ospedale 46, Cagliari, Italy 09100. E-mail: cinziamurgia{at}tiscali.it
The prevalence of gestational diabetes mellitus (GDM) ranges from 1 to 14% of all pregnancies, depending on the population studied and the diagnostic test and its glycemic cutoff, and it mirrors the prevalence of type 2 diabetes (1). The prevalence of GDM in Italy was reported to be 2.3–10% (2).
Sardinia has, with Finland, the highest prevalence in the world of type 1 diabetes and type 1 diabetes–related autoimmune disease (3), while the …
